1. Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
   Nicolas Torres et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
2. Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
   Payal Dhar et al, 2021, Communications Biology CrossRef
3. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer
   Marcelo J. Sakiyama et al, 2019, Experimental and Molecular Pathology CrossRef
4. Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice
   Chenglai Xia et al, 2019, European Journal of Pharmacology CrossRef
5. Innate immune cells for immunotherapy of autoimmune and cancer disorders
   Carolina Schäfer et al, 2017, International Reviews of Immunology CrossRef
6. Prognostic significance of microsatellite instability‑associated pathways and genes in gastric cancer
   Xiaosheng Hang et al, 2018, International Journal of Molecular Medicine CrossRef
7. Stress-induced MICA and MICB molecules in oncology
   S. A. Yurevna et al, 2022, Medical Immunology (Russia) CrossRef
8. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
   Florencia Secchiari et al, 2022, OncoImmunology CrossRef
9. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
   Hormas Ghadially et al, 2017, British Journal of Cancer CrossRef
10. The association between MICA/MICB polymorphism and respiratory syncytial virus infection in children
    Q. Luo et al, 2017, International Journal of Immunogenetics CrossRef
11. Decreased invariant natural killer T‐cell‐mediated antitumor immune response in patients with gastric cancer
    Gabriel Ascui et al, 2020, Immunology & Cell Biology CrossRef
12. Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer
    Karen Toledo-Stuardo et al, 2021, Frontiers in Immunology CrossRef
13. Heat‐killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll‐like receptor 4
    Carolina Hernández et al, 2021, Helicobacter CrossRef
14. A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
    Zesi Liu et al, 2022, Hereditas CrossRef
15. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment
    Ziwen Zheng et al, 2023, International Journal of Molecular Sciences CrossRef
16. microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells
    Haitao Xie et al, 2018, Cytotechnology CrossRef
17. The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
    Ge Tan et al, 2023, Biology CrossRef
18. Leveraging NKG2D Ligands in Immuno-Oncology
    Mercedes Beatriz Fuertes et al, 2021, Frontiers in Immunology CrossRef
19. DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer
    Najibeh Shekari et al, 2020, Journal of Gastrointestinal Cancer CrossRef
20. Prognostic significance of soluble major histocompatibility complex class I-related chain A (sMICA) in gastric cancer
    P Zhao et al, 2018, British Journal of Biomedical Science CrossRef
21. Killer instincts: natural killer cells as multifactorial cancer immunotherapy
    Sarah Nersesian et al, 2023, Frontiers in Immunology CrossRef
22. MICB gene diversity and balancing selection on its promoter region in Yao population in southern China
    Xiang Chen et al, 2016, Human Immunology CrossRef